Literature DB >> 30477394

Entering the Modern Era of Gene Therapy.

Xavier M Anguela1, Katherine A High1.   

Abstract

Gene therapies are gaining momentum as promising early successes in clinical studies accumulate and examples of regulatory approval for licensing increase. Investigators are advancing with cautious optimism that effective, durable, and safe therapies will provide benefit to patients-not only those with single-gene disorders but those with complex acquired diseases as well. While the strategies being translated from the lab to the clinic are numerous, this review focuses on the clinical research that has forged the gene therapy field as it currently stands.

Entities:  

Keywords:  adeno-associated viral vectors; gene therapy; immunotherapy; lentiviral vectors

Year:  2018        PMID: 30477394     DOI: 10.1146/annurev-med-012017-043332

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  72 in total

1.  Hijack of CRISPR defences by selfish genes holds clinical promise.

Authors:  Fyodor D Urnov
Journal:  Nature       Date:  2019-07       Impact factor: 49.962

Review 2.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

3.  In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness.

Authors:  Wei-Hsi Yeh; Olga Shubina-Oleinik; Jonathan M Levy; Bifeng Pan; Gregory A Newby; Michael Wornow; Rachel Burt; Jonathan C Chen; Jeffrey R Holt; David R Liu
Journal:  Sci Transl Med       Date:  2020-06-03       Impact factor: 17.956

4.  Cationic Dendrimers for siRNA Delivery: An Overview of Methods for In Vitro/In Vivo Characterization.

Authors:  Erik Laurini; Suzana Aulic; Domenico Marson; Maurizio Fermeglia; Sabrina Pricl
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

6.  Skipped Over: Tuning Natural Killer Cells Toward HIV Through Alternative Splicing.

Authors:  Daniel R Ram; Kyle Kroll; R Keith Reeves
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-28       Impact factor: 2.205

Review 7.  Emerging treatments for progressive myoclonus epilepsies.

Authors:  Antonella Riva; Alberto Guglielmo; Ganna Balagura; Francesca Marchese; Elisabetta Amadori; Michele Iacomino; Berge Arakel Minassian; Federico Zara; Pasquale Striano
Journal:  Expert Rev Neurother       Date:  2020-03-17       Impact factor: 4.618

8.  Patient and family social media use surrounding a novel treatment for a rare genetic disease: a qualitative interview study.

Authors:  Alexander A Iyer; Julie R Barzilay; Holly K Tabor
Journal:  Genet Med       Date:  2020-06-30       Impact factor: 8.822

Review 9.  Advances in genome editing for genetic hearing loss.

Authors:  Ning Ding; Sangsin Lee; Matan Lieber-Kotz; Jie Yang; Xue Gao
Journal:  Adv Drug Deliv Rev       Date:  2020-05-07       Impact factor: 15.470

Review 10.  Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.

Authors:  Nisi Zhang; James Wang; Josquin Foiret; Zhifei Dai; Katherine W Ferrara
Journal:  Adv Drug Deliv Rev       Date:  2021-07-30       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.